RxDoctor Payments Data

Ann Lowe

Medical Oncology · Palo Alto, CANPI 1013278811

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $914,724 of the $923,035 with a category attached, or 99.1%. Every reported general payment came from a single manufacturer, Rigel Pharmaceuticals, Inc.. Reporting peaked in 2020 at $307,648 and has fallen 90.7% since, to $28,600 in 2023. Among medical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$923,035in general payments, 2019–2025

Across 37 payments — averaging $24,947 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rigel Pharmaceuticals, Inc.$923K

What the payments were for

  • Consulting fees$914,72499%
  • Travel & lodging$8,3111%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Rigel Pharmaceuticals, Inc.37$923,035

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$923,035 in reported general payments places this provider in the 95th percentile of 379 medical oncology providers in California.

See all medical oncology providers in California →

Other medical oncology in Palo Alto

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →